← Back
Lycia Therapeutics
LYCA · listed on Nasdaq · worth $1.39 billion
$27.73
+10.70% on Oct 29
One insider bought $37.65 million of Lycia Therapeutics stock in the last two weeks. The buyer was Venrock Healthcare Capital Partners III.
Green dot = an insider boughtA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
8.8M shares
17% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider bought Lycia Therapeutics stock and none sold.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
10% owner
Venrock Healthcare Capital Partners III
Bought $35M on Oct 26 — 1,944,444 shares at $18.00, held through a trust or family, 29% of what they now own.
No earlier purchases to measure
All reports
Every insider trade and SEC report we hold for Lycia Therapeutics.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Oct 27BoughtVenrock Healthcare Capital Partners IIIOct 27 · 10% owner+0.5%via a trust or family31,067 @ $26.84$833.8K
Oct 27BoughtVenrock Healthcare Capital Partners IIIOct 27 · 10% owner+0.1%via a trust or family8,729 @ $25.84$225.6K
Oct 27BoughtVenrock Healthcare Capital Partners IIIOct 27 · Traded Oct 26 · 10% owner+0.1%via a trust or family8,261 @ $26.97$222.8K
Oct 27BoughtVenrock Healthcare Capital Partners IIIOct 27 · Traded Oct 26 · 10% owner+29%via a trust or family1,944,444 @ $18.00$35M
Oct 27BoughtVenrock Healthcare Capital Partners IIIOct 27 · Traded Oct 23 · 10% owner+54%via a trust or family28,379 @ $26.11$741K
1 more with Pro →